Affiliation:
1. Frauenarzt/Spezielle Geburtshilfe und Perinatalmedizin, Ochsenhausen, Germany
2. Abteilung für Medizinische Statistik, Biomathematik und Informationsverarbeitung, Universitätsmedizin Mannheim, Ruprecht-Karls-Universität Heidelberg Medizinische
Fakultät Mannheim, Mannheim, Germany
Abstract
AbstractThe aim of this study was to determine the extent to which regular monitoring of maternal free thyroxine level and pregnancy-adapted L-thyroxine replacement therapy before and during
pregnancy in patients with existing or newly diagnosed latent and manifest hypothyroidism as well as hypothyroxinemia can influence the rate of premature births.This is a retrospective cohort study assessing 1440 pseudonymized survey questionnaires to evaluate the risks of premature birth with two study groups from the same medical practice, and
a nationally recruited control group. Study group A (n = 360) had already been taking L-thyroxine prior to conception, study group B (n = 580) started taking it after conception. Both
study groups had a maximum gestational age of 12 + 0 GW. In the study groups, TSH and free thyroxine levels were determined regularly for dose adjustment purposes. The aim was to keep the
free thyroxine level in the euthyroid hyperthyroxinemic range within the pregnancy adapted reference range. The control group (n = 500) had taken L-thyroxine during pregnancy according to
criteria that were not known, as the questionnaire did not include any questions regarding this matter. Taking other risk factors into account, the influence of pregnancy-adapted
L-thyroxine replacement therapy on the rate of premature births was determined using logistic regression analysis.Compared with the control group, the premature birth rate was 70% lower (p < 0.0001) in study group A and 42% lower in study group B (p = 0.0086), while the odds ratio, at 3.46, was
particularly significant in study group A. High blood pressure (odds ratio 5.21), body mass index per kg/m2 (odds ratio 0.91) and S. p. premature birth were identified as other
independent risk factors.The results show an association between more intensive thyroid diagnostics and pregnancy-adapted L-thyroxine replacement therapy and a decrease in premature births. Further studies should
be conducted to confirm these results.
Subject
Maternity and Midwifery,Obstetrics and Gynecology
Reference28 articles.
1. Frühgeburtlichkeit;H Stepan;Frauenheilkunde up2date,2010
2. Prevention of Preterm Birth;ID Ivanov;J Biomed Clin Res,2018
3. The prevention, diagnosis and treatment of premature labor;E Schleussner;Dtsch Arztebl Int,2013
4. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology,
Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth;R Berger;Geburtshilfe Frauenheilkd,2023
5. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) – Part 2 with Recommendations on the Tertiary
Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of Membranes;R Berger;Geburtshilfe Frauenheilkd,2023